Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-07
DOI
10.3389/fonc.2020.00902
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pre-existing commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor-positive breast cancer
- (2019) Claire Buchta Rosean et al. CANCER RESEARCH
- The diversity of gut microbiome is associated with favorable responses to anti-PD-1 immunotherapy in Chinese non-small cell lung cancer patients
- (2019) Yueping Jin et al. Journal of Thoracic Oncology
- Differences in Fecal Gut Microbiota, Short-Chain Fatty Acids and Bile Acids Link Colorectal Cancer Risk to Dietary Changes Associated with Urbanization Among Zimbabweans
- (2019) L. Katsidzira et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
- (2019) Evan Bolyen et al. NATURE BIOTECHNOLOGY
- The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy
- (2019) Romy Aarnoutse et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†
- (2018) F Cardoso et al. ANNALS OF ONCOLOGY
- Comparison of Microbiota in Patients Treated by Surgery or Chemotherapy by 16S rRNA Sequencing Reveals Potential Biomarkers for Colorectal Cancer Therapy
- (2018) Xingming Deng et al. Frontiers in Microbiology
- 16S rRNA gene sequencing reveals altered composition of gut microbiota in individuals with kidney stones
- (2018) Ruiqiang Tang et al. Urolithiasis
- Breast Cancer and Its Relationship with the Microbiota
- (2018) Mariana Fernández et al. International Journal of Environmental Research and Public Health
- Breast cancer in postmenopausal women is associated with an altered gut metagenome
- (2018) Jia Zhu et al. Microbiome
- Mucosal microbiome dysbiosis in gastric carcinogenesis
- (2017) Olabisi Oluwabukola Coker et al. GUT
- Gut microbiota modulation of chemotherapy efficacy and toxicity
- (2017) James L. Alexander et al. Nature Reviews Gastroenterology & Hepatology
- Anticancer effects of the microbiome and its products
- (2017) Laurence Zitvogel et al. NATURE REVIEWS MICROBIOLOGY
- Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
- (2017) Norikazu Masuda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intestinal Proportion of Blautia sp. is Associated with Clinical Stage and Histoprognostic Grade in Patients with Early-Stage Breast Cancer
- (2017) Trang H. Luu et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Gut microbiota dysbiosis contributes to the development of hypertension
- (2017) Jing Li et al. Microbiome
- Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine–Induced Hand-Foot Syndrome
- (2017) Yoon-Sim Yap et al. JAMA Oncology
- A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression
- (2016) Shuanghong Jiang et al. ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY
- Clinical overview of metronomic chemotherapy in breast cancer
- (2015) Elisabetta Munzone et al. Nature Reviews Clinical Oncology
- Intermittent Metronomic Drug Schedule Is Essential for Activating Antitumor Innate Immunity and Tumor Xenograft Regression
- (2015) Chong-Sheng Chen et al. NEOPLASIA
- Potential of fecal microbiota for early-stage detection of colorectal cancer
- (2014) G. Zeller et al. Molecular Systems Biology
- Metronomics: towards personalized chemotherapy?
- (2014) Nicolas André et al. Nature Reviews Clinical Oncology
- A decrease of the butyrate-producing speciesRoseburia hominisandFaecalibacterium prausnitziidefines dysbiosis in patients with ulcerative colitis
- (2013) Kathleen Machiels et al. GUT
- Human Gut Microbiome and Risk for Colorectal Cancer
- (2013) Jiyoung Ahn et al. JNCI-Journal of the National Cancer Institute
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells
- (2012) Eddy Pasquier et al. ANGIOGENESIS
- Twin Study Indicates Loss of Interaction Between Microbiota and Mucosa of Patients With Ulcerative Colitis
- (2011) Patricia Lepage et al. GASTROENTEROLOGY
- Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
- (2010) Nadja Larsen et al. PLoS One
- Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
- (2009) E. Briasoulis et al. CLINICAL CANCER RESEARCH
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
- (2008) H. Sokol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More